TBP - TATA-Box Binding Protein

Migration, Crosslink

📖

TBP - TATA-Box Binding Protein

active

wiki page Created: 2026-04-02T07:19:29 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-tbp

📖 Wiki Page

gene1363 wordssynced 2026-04-02

TBP (TATA-Box Binding Protein)

Overview

TBP (TATA-Box Binding Protein) is a general transcription factor essential for RNA polymerase II-mediated transcription initiation. Encoded by the TBP gene located on chromosome 6q27, this protein plays a fundamental role in regulating gene expression across all eukaryotic cells. TBP is particularly notable in neurodegeneration research due to its involvement in multiple polyglutamine diseases, most notably spinocerebellar ataxia type 17 (SCA17), and its broader implications in transcriptional dysfunction observed in [Alzheimer's disease](/diseases/alzheimers-disease) and [Huntington's disease](/diseases/huntingtons). [@kikuchi2000]

...

TBP (TATA-Box Binding Protein)

Overview

Mermaid diagram (expand to render)

TBP (TATA-Box Binding Protein) is a general transcription factor essential for RNA polymerase II-mediated transcription initiation. Encoded by the TBP gene located on chromosome 6q27, this protein plays a fundamental role in regulating gene expression across all eukaryotic cells. TBP is particularly notable in neurodegeneration research due to its involvement in multiple polyglutamine diseases, most notably spinocerebellar ataxia type 17 (SCA17), and its broader implications in transcriptional dysfunction observed in [Alzheimer's disease](/diseases/alzheimers-disease) and [Huntington's disease](/diseases/huntingtons). [@kikuchi2000]

| Property | Value |
|----------|-------|
| Gene Symbol | TBP |
| Full Name | TATA-Box Binding Protein |
| Chr Location | 6q27 |
| NCBI Gene ID | 6908 |
| OMIM ID | 600075 |
| Ensembl ID | ENSG00000112592 |
| UniProt ID | P20226 |
| Encoded Protein | TATA-Binding Protein |
| Associated Diseases | Huntington's disease, spinocerebellar ataxia type 17, Alzheimer's disease |

</div>

Gene Structure and Molecular Biology

Genomic Organization

The TBP gene spans approximately 32 kb and consists of 8 exons encoding a 339-amino acid protein. The gene contains a polymorphic CAG repeat in the first exon that encodes a polyglutamine (polyQ) tract in the N-terminal domain. This polyQ tract is the critical region implicated in disease pathogenesis.

Protein Structure

The TBP protein contains several distinct functional domains:

N-terminal domain (aa 1-159): Glutamine-rich region containing the polymorphic polyQ tract. This domain is involved in protein-protein interactions with various transcription cofactors and can undergo post-translational modifications including phosphorylation, sumoylation, and acetylation.
C-terminal domain (aa 160-339): The conserved "saddle-shaped" DNA-binding domain that binds specifically to the TATA box sequence (TATAAA) in gene promoters. This domain is highly conserved across eukaryotes and is essential for TBP's function as a general transcription factor. [@friedman2008]

Normal Physiological Functions

TBP performs several critical cellular functions:

Transcription Initiation: TBP is the DNA-binding component of the transcription factor IID (TFIID) complex. It binds to the TATA box in promoter regions and facilitates the recruitment of RNA polymerase II and other general transcription factors to form the pre-initiation complex (PIC).

Promoter Recognition: TBP provides promoter specificity by recognizing TATA box-containing genes. Estimates suggest approximately 10-20% of human promoters contain canonical TATA boxes.

Transcriptional Regulation: Beyond basal transcription, TBP interacts with various transcriptional activators and repressors to modulate gene expression in response to cellular signals.

Transcription-Coupled DNA Repair: TBP is involved in the transcription-coupled nucleotide excision repair (TC-NER) pathway, particularly for genes actively transcribed by RNA polymerase II.

Mitochondrial Transcription: TBP also functions in mitochondrial DNA transcription as part of the mitochondrial transcription factor A (TFAM) complex. [@benn2008]

Expression Patterns

TBP is ubiquitously expressed as a housekeeping gene, with highest levels in metabolically active tissues:

| Tissue Type | Expression Level |
|-------------|------------------|
| Brain (cortex, hippocampus, cerebellum) | Highest |
| Liver | High |
| Kidney | High |
| Heart | Moderate |
| Skeletal muscle | Moderate |
| Most other tissues | Low-moderate |

In the central nervous system, TBP is expressed in:

Cortical pyramidal neurons
Hippocampal pyramidal neurons and granule cells
Cerebellar Purkinje cells
Cerebellar granule cells
Dopaminergic neurons in the substantia nigra

The Allen Brain Atlas demonstrates particularly high TBP expression in neurons with high transcriptional activity, reflecting the protein's essential role in general transcription.

Disease Associations

Spinocerebellar Ataxia Type 17 (SCA17)

SCA17 is caused by CAG repeat expansion in the TBP gene, making it a member of the polyglutamine (polyQ) disease family that includes [Huntington's disease](/diseases/huntingtons), [spinocerebellar ataxia type 1](/diseases/sca1), and several other ataxias.

Molecular Pathogenesis

Normal repeat range: 25-42 CAG repeats
Pathogenic range: 45-66+ repeats
Intermediate range: 43-49 repeats (may cause reduced penetrance)

The expanded polyQ tract leads to:

Protein misfolding: Mutant TBP adopts abnormal conformational states

Aggregation: TBP forms intracellular inclusions and aggregates

Transcriptional dysregulation: Altered TBP function disrupts normal gene expression patterns

Neuronal toxicity: Progressive neurodegeneration in cerebellum and other brain regions

Clinical Features

SCA17 presents with:

Progressive cerebellar ataxia (gait and limb incoordination)
Dementia and cognitive decline
Psychiatric symptoms (depression, anxiety, psychosis)
Extrapyramidal signs (parkinsonism, dystonia)
Dysarthria and dysphagia
Variable age of onset (typically 20-50 years)

Recent Research Findings

Recent studies have identified:

Digenic inheritance: TBP can interact with STUB1 to cause complex ataxia-dementia phenotypes
CAA interrupt motifs: CAA interruptions within the CAG repeat can modify disease phenotype
Genetic modifiers: Intermediate repeat expansions may act as modifiers in other spinocerebellar ataxias

[@fung2023]

Huntington's Disease (HD)

Although HD is caused by HTT gene mutations, TBP plays a significant role in HD pathogenesis:

Transcriptional dysregulation: Mutant huntingtin protein alters TBP function and nuclear localization
TBP aggregation: TBP is recruited into huntingtin inclusions in HD brains
Therapeutic target: Restoring proper transcription through TBP modulation is an active research area

Studies have shown that TBP levels and modifications are altered in HD models and patient tissues, suggesting TBP dysfunction contributes to the broader transcriptional dysregulation characteristic of HD. [@govorov2011]

Alzheimer's Disease

TBP involvement in [Alzheimer's disease](/diseases/alzheimers-disease) relates to:

Transcriptional dysregulation: AD brains show widespread transcriptional changes, with TBP playing a central role in general transcription machinery disruption
Tau pathology interaction: TBP may interact with pathological tau species, as both are nuclear proteins affected in AD
Therapeutic implications: Modulating TBP function could potentially restore normal transcriptional patterns in AD

Research using AD brain tissue and models has demonstrated altered TBP post-translational modifications and nuclear import/export dynamics. [@schneider2019]

Parkinson's Disease

TBP has been associated with [Parkinson's disease](/diseases/parkinsons-disease) through:

Transcriptional dysregulation in dopaminergic neurons
Possible interactions with alpha-synuclein pathology
Altered expression in PD brain regions

Post-Translational Modifications in Neurodegeneration

TBP undergoes several modifications relevant to neurodegeneration:

Phosphorylation: TBP phosphorylation affects its DNA-binding activity and interactions with cofactors. Stress-activated kinases can modify TBP in disease contexts.

Sumoylation: TBP can be sumoylated, and this modification is altered in polyglutamine diseases. Sumoylation affects TBP's transcriptional activity and may influence aggregation.

Acetylation: TBP acetylation modulates its function and can be dysregulated in neurodegeneration.

[@hsieh2012]

Therapeutic Approaches

Several therapeutic strategies targeting TBP are under investigation:

| Approach | Mechanism | Status |
|----------|-----------|--------|
| Gene silencing | Reduce mutant TBP expression | Preclinical |
| Aggregation inhibitors | Prevent TBP aggregation | Research |
| Transcriptional modulators | Restore normal transcription | Experimental |
| Protein replacement | Deliver functional TBP | Theoretical |
| Small molecule stabilizers | Stabilize normal TBP conformation | Discovery |

The polyglutamine tract makes TBP an attractive target for:

RNA interference (RNAi) approaches
Antisense oligonucleotide (ASO) therapy
CRISPR-based gene editing
Small molecule chaperones

Interaction Network

TBP interacts with numerous proteins relevant to neurodegeneration:

TFIID complex components: TAF1, TAF2, TAF4, TAF6, TAF9, TAF10, TAF11, TAF12
Transcription factors: TFIIA, TFIIB, TFIIE, TFIIF, TFIIH
Coactivators: p300/CBP, GCN5, PCAF
Nuclear receptors: steroid hormone receptors
Polyglutamine disease proteins: huntingtin, ataxin-1, ataxin-3, ataxin-7
Aggregation-related: SQSTM1/p62, ubiquilin

Research Models

Several model systems have advanced understanding of TBP in neurodegeneration:

Cell culture: Neuronal and non-neuronal cell lines expressing mutant TBP
Drosophila: Drosophila models showing polyQ-expanded TBP causes neurodegeneration
Mouse models: Transgenic mice expressing mutant TBP recapitulate SCA17 phenotype
Induced neurons: Patient-derived iPSC neurons for disease modeling

[@fujigasaki2001]

External Links

[NCBI Gene: TBP](https://www.ncbi.nlm.nih.gov/gene/6908)
[UniProt: TBP](https://www.uniprot.org/uniprot/P20226)
[OMIM: TBP](https://www.omim.org/entry/600075)
[Allen Brain Atlas](https://brain-map.org/)
[PubMed](https://pubmed.ncbi.nlm.nih.gov/)
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/)

References

[Kikuchi et al., SCA17 and TBP (2000)](https://doi.org/10.1093/hmg/9.14.2073)

[Friedman et al., TBP in transcription (2008)](https://doi.org/10.1016/S0092-8674(00)81401-4)

[Benn et al., TBP in neurodegeneration (2008)](https://doi.org/10.1093/hmg/ddn250)

[Roy et al., TBP in polyglutamine diseases (2017)](https://doi.org/10.1016/j.tcb.2017.03.005)

[Choudhury et al., TBP aggregation in neurodegeneration (2017)](https://doi.org/10.1093/hmg/ddx120)

[Fung et al., SCA17 genotype-phenotype correlations (2023)](https://doi.org/10.1002/mds.29342)

[Schneider et al., TBP and transcriptional dysregulation in AD (2019)](https://doi.org/10.1186/s13073-019-0623-1)

[Fujigasaki et al., SCA17 transgene models (2001)](https://doi.org/10.1093/hmg/10.23.2721)

[Govorov et al., TBP modifications in HD models (2011)](https://doi.org/10.1016/j.neurobiolaging.2010.09.014)

[Hsieh et al., TBP sumoylation in neurodegeneration (2012)](https://doi.org/10.1074/jbc.M111.306639)

Pathway Diagram

The following diagram shows the key molecular relationships involving TBP - TATA-Box Binding Protein discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

TBP

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-tbp
kg_node_id	TBP
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-74f1f9ff220f
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-tbp'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

22

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TBP - TATA-Box Binding Protein

TBP (TATA-Box Binding Protein)

Overview

TBP (TATA-Box Binding Protein)

Overview

Gene Structure and Molecular Biology

Genomic Organization

Protein Structure

Normal Physiological Functions

Expression Patterns

Disease Associations

Spinocerebellar Ataxia Type 17 (SCA17)

Molecular Pathogenesis

Clinical Features

Recent Research Findings

Huntington's Disease (HD)

Alzheimer's Disease

Parkinson's Disease

Post-Translational Modifications in Neurodegeneration

Therapeutic Approaches

Interaction Network

Research Models

See Also

External Links

References

Pathway Diagram

💬 Discussion